A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus

[1]  Madhavrao D. Chavan,et al.  Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review , 2023, Virology.

[2]  Simian Huang,et al.  Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak , 2023, Annals of Internal Medicine.

[3]  A. Bhagavathula,et al.  Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression , 2023, Scientific reports.

[4]  Peter E. Wu,et al.  Tecovirimat for monkeypox , 2022, Canadian Medical Association Journal.

[5]  N. Kifli,et al.  Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies , 2022, Viruses.

[6]  J. Rodríguez-Peralto,et al.  Monkeypox: is topical cidofovir a good idea? , 2022, Clinical and experimental dermatology.

[7]  P. Fournier,et al.  Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France , 2022, Emerging infectious diseases.

[8]  G. Poland,et al.  Prevention of monkeypox with vaccines: a rapid review , 2022, The Lancet Infectious Diseases.

[9]  V. Calvez,et al.  Viral loads in clinical samples of men with monkeypox virus infection: a French case series , 2022, The Lancet. Infectious diseases.

[10]  J. Peris-García,et al.  Genitourinary Lesions Due to Monkeypox , 2022, European urology.

[11]  S. Laivacuma,et al.  The virology of human monkeypox virus (hMPXV): A brief overview , 2022, Virus research.

[12]  Stuart H. Cohen,et al.  Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. , 2022, JAMA.

[13]  C. Charpentier,et al.  Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France , 2022, Annals of Internal Medicine.

[14]  Y. Yazdanpanah,et al.  Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  P. Ortiz-Romero,et al.  Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study , 2022, The Lancet.

[16]  D. Chilton,et al.  Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series , 2022, BMJ.

[17]  A. Rodríguez-Morales,et al.  Ophthalmic manifestations of monkeypox virus , 2022, Eye.

[18]  A. Antinori,et al.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.

[19]  S. Coppens,et al.  Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium , 2022, Nature Medicine.

[20]  M. Ordobás Gavín,et al.  Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  J. Blanco,et al.  Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  G. Palacios,et al.  Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects , 2022, The Journal of infection.

[23]  R. Byrne,et al.  Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis , 2022, The Lancet. Infectious diseases.

[24]  S. Nematollahi,et al.  Monkeypox: A Contemporary Review for Healthcare Professionals , 2022, Open forum infectious diseases.

[25]  R. Mungmunpuntipantip,et al.  Dysphagia and Monkeypox: A Consideration , 2022, Dysphagia.

[26]  David H. Philpott,et al.  Monkeypox Outbreak — Nine States, May 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[27]  Allen Cheng,et al.  Monkeypox infection presenting as genital rash, Australia, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  S. Ladhani,et al.  Monkeypox vaccines in pregnancy: lessons must be learned from COVID-19 , 2022, The Lancet Global Health.

[29]  E. Nicastri,et al.  Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  J. Wallinga,et al.  Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  G. Spiteri,et al.  Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[32]  Caroline A. Schrodt,et al.  Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021 , 2022, MMWR. Morbidity and mortality weekly report.

[33]  Madhavrao D. Chavan,et al.  Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review , 2022, Journal of medical virology.

[34]  F. Lienert,et al.  The changing epidemiology of human monkeypox—A potential threat? A systematic review , 2021, medRxiv.

[35]  N. Yamamoto,et al.  Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain , 2021, Biology.

[36]  Y. Nakazawa,et al.  Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model , 2021, mSphere.

[37]  Andrew T. Russo,et al.  An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications , 2020, Expert review of anti-infective therapy.

[38]  M. Koopmans,et al.  Human Monkeypox , 2019, Infectious Disease Clinics of North America.

[39]  Joachim Hornung,et al.  Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox. , 2019, The New England journal of medicine.

[40]  A. Albright,et al.  The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox. , 2019, Antiviral research.

[41]  FDA approves the first drug with an indication for treatment of smallpox , 2018, Case Medical Research.

[42]  M. Reynolds,et al.  Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research , 2017, Viruses.

[43]  J. Muyembe,et al.  Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo. , 2017, The Journal of infectious diseases.

[44]  L. Nolen,et al.  Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo , 2016, Emerging infectious diseases.

[45]  C. Murphy,et al.  Evaluation of therapeutic interventions for vaccinia virus keratitis. , 2011, The Journal of infectious diseases.

[46]  G. Andrei,et al.  Cidofovir Activity against Poxvirus Infections , 2010, Viruses.

[47]  Chelsea M. Byrd,et al.  ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification , 2009, Antimicrobial Agents and Chemotherapy.

[48]  R. Holman,et al.  Clinical manifestations of human monkeypox influenced by route of infection. , 2006, The Journal of infectious diseases.

[49]  S. Bavari,et al.  Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  J. Sejvar,et al.  Clinical characteristics of human monkeypox, and risk factors for severe disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  R. Hopkins,et al.  Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  D. Henderson,et al.  Smallpox vaccination: a review, part II. Adverse events. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  R. Semba.  The ocular complications of smallpox and smallpox immunization. , 2003, Archives of ophthalmology.

[54]  M. Bray,et al.  Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections , 2003, Antiviral research.

[55]  P E Fine,et al.  The transmission potential of monkeypox virus in human populations. , 1988, International journal of epidemiology.

[56]  Z. Ježek,et al.  Human monkeypox: clinical features of 282 patients. , 1987, The Journal of infectious diseases.

[57]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[58]  Y. Tretyakova,et al.  Clinical features and management of human monkeypox , 2023, Scripta Medica.

[59]  P. Ortiz-Romero,et al.  Clinical Presentation and Virological Assessment of Confirmed Human Monkeypox Virus Cases in Spain : A Prospective Cohort Study , 2022, SSRN Electronic Journal.

[60]  K. Dhama,et al.  Animal-Origin Viral Zoonoses , 2020 .

[61]  C. Zimmerman,et al.  – a BrieF OvervieW , 2009 .

[62]  Janine A. Smith,et al.  The ocular complications of smallpox and smallpox immunization. , 2004, Archives of ophthalmology.

[63]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..